Claudia Gandolfo Selected Research

Claudia Gandolfo Research Topics

Disease

8	Infections 11/2022 - 01/2016
7	Neoplasms (Cancer) 01/2023 - 09/2015
7	COVID-19 01/2023 - 01/2021
2	Reinfection 01/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2017
2	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 04/2016
2	Fever (Fevers) 04/2016 - 09/2015
2	Arthralgia (Joint Pain) 04/2016 - 09/2015
2	Rhinitis 04/2016 - 09/2015
1	Post-Acute COVID-19 Syndrome 01/2023
1	Inflammation (Inflammations) 11/2022
1	Virus Diseases (Viral Diseases) 11/2022
1	Measles 02/2020
1	Meningitis 12/2019
1	Wounds and Injuries (Trauma) 12/2019
1	Cardiogenic Shock 01/2019
1	Human Influenza (Influenza) 01/2019
1	Myocarditis (Carditis) 01/2019
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Erythema 04/2016
1	Conjunctivitis 04/2016
1	Rectal Neoplasms (Rectal Cancer) 04/2016
1	Hypothyroidism 09/2015
1	Cough 09/2015
1	Hypertension (High Blood Pressure) 09/2015

Drug/Important Bio-Agent (IBA)

5	Neutralizing AntibodiesIBA 05/2022 - 02/2020
5	VaccinesIBA 01/2022 - 09/2015
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
3	tetraphenylporphine sulfonate (TPPS)IBA 04/2018 - 09/2015
3	Peptides (Polypeptides)IBA 04/2018 - 09/2015
3	Thymidylate SynthaseIBA 04/2018 - 09/2015
3	EpitopesIBA 04/2018 - 09/2015
2	CytokinesIBA 11/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2016
2	AntibodiesIBA 02/2020 - 04/2016
2	Interleukin-2 (IL2)IBA 04/2016 - 09/2015
2	Protein Subunit VaccinesIBA 04/2016 - 09/2015
2	EnzymesIBA 04/2016 - 09/2015
1	Monoclonal AntibodiesIBA 01/2023
1	cilgavimabIBA 01/2023
1	cilgavimab and tixagevimab drug combinationIBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 09/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	AntigensIBA 01/2022
1	atezolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	durvalumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Glycoproteins (Glycoprotein)IBA 08/2021
1	Messenger RNA (mRNA)IBA 05/2021
1	BNT162 VaccineIBA 05/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Measles VaccineIBA 02/2020
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 02/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	Bevacizumab (Avastin)FDA Link 09/2017
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	Endothelial Growth FactorsIBA 09/2017
1	Etoposide (VP 16)FDA LinkGeneric 09/2017
1	Gemcitabine FDA Link 04/2016
1	sargramostim (Leukine)FDA Link 04/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2015

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 04/2016
2	Therapeutics 01/2022 - 10/2021
1	Off-Label Use 01/2023
1	Fecal Microbiota Transplantation 01/2022
1	Extracorporeal Membrane Oxygenation 01/2019
1	Radiotherapy 09/2017
1	Immunotherapy 04/2016